Spectral Medical Inc. (OTCMKTS:EDTXF - Get Free Report) was the target of a significant decline in short interest in October. As of October 15th, there was short interest totalling 94,800 shares, a decline of 5.2% from the September 30th total of 100,000 shares. Based on an average trading volume of 14,500 shares, the short-interest ratio is currently 6.5 days.
Spectral Medical Stock Up 5.5 %
OTCMKTS EDTXF traded up $0.02 during trading hours on Thursday, reaching $0.44. The company's stock had a trading volume of 9,066 shares, compared to its average volume of 18,268. Spectral Medical has a 1 year low of $0.23 and a 1 year high of $0.55. The company has a market capitalization of $122.30 million, a price-to-earnings ratio of -8.27 and a beta of 0.93. The firm's 50-day moving average price is $0.46 and its 200-day moving average price is $0.40.
Spectral Medical (OTCMKTS:EDTXF - Get Free Report) last posted its earnings results on Friday, August 9th. The company reported ($0.01) earnings per share for the quarter. The company had revenue of $0.34 million for the quarter.
About Spectral Medical
(
Get Free Report)
Spectral Medical Inc focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, and internationally. The company markets Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream.
See Also
Before you consider Spectral Medical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Spectral Medical wasn't on the list.
While Spectral Medical currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
